Drug Trial Radar · NCT00269542
Impact of Zinc Supplementation on Mortality and Hospitalizations in Children Aged 1 Months to 23 Months
Last checked: Nov 19, 2026Latest source record: Jul 1, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
94,359
Actual
Start
Feb 2002
Primary completion
Mar 2003
Study completion Aug 2003
Sponsor
- Lead sponsor
- Society for Applied StudiesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- World Health Organization; All India Institute of Medical Sciences
- First posted
- Dec 23, 2005
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 1 month, up to 35 months
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Children, aged 1 months to 23 months, in the intervention households received zinc, iron and folic acid and those in the control households were administered iron and folic acid (IFA) alone for a period of one year. The primary outcomes were hospitalizations and deaths during this period.
Conditions
- Morbidity
- Mortality
- Diarrhea
- Pneumonia
Interventions
Zinc and iron folic acid - InterventionDrug
The intervention group tablet contained 10 mg of elemental zinc, 12.5 mg of iron and 50 micrograms of folic acid.
Iron Folic Acid alone - PlaceboDrug
The control group tablets were similar in composition, appearance and taste except it contained placebo for zinc.
Primary outcomes
What the sponsor says the trial is designed to measure.
- - to determine the impact of daily oral supplementation of zinc (5 mg per day to infants aged less than 6 months and 10 mg per day to older children) and iron folic acid to children aged 1-23 months for a period of upto 12 months on all-cause mortality,Time frame: 3 monthly home visits
- - to determine the impact of daily oral supplementation of zinc and iron folic acid to children 1-23 months for a period of upto 12 months on overall and diarrhea and pneumonia specific hospital admissions.Time frame: 3 monthly home visits
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.